-+ 0.00%
-+ 0.00%
-+ 0.00%

Bruker takes majority stake in organ-on-a-chip developer MIMETAS

PUBT·08/11/2026 05:54:39
Listen to the news
Bruker takes majority stake in organ-on-a-chip developer MIMETAS
  • Bruker took a majority stake in Dutch organ-on-a-chip developer MIMETAS.
  • The deal pairs MIMETAS’ tissue-model platforms with Bruker’s proteomics, metabolomics, imaging, and molecular analysis tools.
  • MIMETAS will continue to operate under its own name with its existing management team.
  • Ontwikkelingsmaatschappij Oost-Nederland NV, an early investor, said proceeds will be redeployed into new innovative startups.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ontwikkelingsmaatschappij Oost-Nederland NV published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.